Bristol-Myers Squibb: Our Commitment to Chronic Hepatitis B

Chronic hepatitis B is a significant global health threat that is under recognized.1 In the United States, approximately 1.4 to 2.0 million individuals are chronically infected with the disease. Due to the fact that more than two-thirds of those with chronic hepatitis B show no signs or symptoms, it is estimated that 65 percent of infected Americans remain unaware of their viral infection.